Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00824603 · ClinicalTrials.gov registry record
Impact of Continuing Medical Education (CME) Insulin Program
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 294
- Enrollment target
NCT00824603: Completed study, sponsored by HealthPartners Institute.
NCT00824603 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 294 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00824603 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 294 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2006-06 |
| Est. Completion | 2009-08 |
What the finished NCT00824603 record still lists
NCT00824603 is an observational study that tracks outcomes without assigning an intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00824603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00824603 about?
NCT00824603 is a clinical study titled "Impact of Continuing Medical Education (CME) Insulin Program". The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.
What is the current status of trial NCT00824603?
This trial is currently completed. The enrollment target is 294 participants. The study started on 2006-06. Estimated completion is 2009-08.
Who is sponsoring clinical trial NCT00824603?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia